Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater...

Area of Science:

• Cardiovascular Medicine
• Genetics
• Public Health

Background:

• Familial Hypercholesterolemia (FH) is a prevalent, serious monogenic disorder of lipoprotein metabolism.
• It significantly increases the risk of premature coronary heart disease, with an estimated 65,000 undiagnosed cases in Australia.
• Many FH patients are undertreated, highlighting the need for improved detection and management strategies.

Purpose of the Study:

• To describe the development and design of the FH Australasia Network Registry.
• To establish a standardized, high-quality, and cost-effective system of care for FH patients.
• To provide a blueprint for developing similar FH registries in other countries.

Main Methods:

• Collaborative development involving government, patient networks, clinical networks, and research groups.
• Utilized the open-source, web-based Rare Disease Registry Framework for its modularity, scalability, and security.
• Informed by extensive stakeholder engagement to meet diverse clinical demands.

Main Results:

• The FH Australasia Network Registry was successfully developed and implemented.
• The chosen framework ensures adaptability to evolving clinical needs and regional variations.
• The registry serves as a critical tool for enhancing FH care and research.

Conclusions:

• Early detection, cascade family testing, and adequate treatment are crucial for improving FH patient outcomes.
• Patient registries are essential for advancing FH knowledge and care globally.
• The FH Australasia Network Registry model offers valuable insights for establishing similar initiatives worldwide.